MarketInOut Stock Screener Log In | Sign Up

Takeda Pharmaceutical Co Ltd ADR

NYSE • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/30/2026
Takeda Pharmaceutical Co Ltd ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNYSE
Market Capitalization66,805 mln
Float3,195 mln
Earnings Date01/28/2027

EPS

0.07
Overpriced

P / E

299
Bubble territory

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.48
Borderline

1-Year Forecast

23.08
Modest upside

Relative Strength

89 / 100
Strongly outperforming

Business Description

Founded in 1781 and based in Tokyo, Takeda is one of the world's leading pharmaceutical companies, developing and selling medicines across a range of treatment areas including digestive health, cancer, rare diseases, and mental health. The company markets dozens of established drug brands globally and works alongside a broad network of research and industry partners to discover and bring new treatments to patients.

Key Fundamentals

EPS0.07
P/E299
ROE0.54
RPS9.53
ROIC4.58
ROA0.26
Interest Cover2.86
EBITDA, mln6,180
EV / EBITDA15.30
EV / EBIT51.09
Revenue, mln29,820
EV / Revenue3.17

Quote Details

Last 20.91
Change 0.9 (4.5%)
Open 21.00
Volume 4,540,829
Turnover 94,948,736
Average Volume 2,861,441

Financial Ratios

Pre-Tax Profit Margin-0
Leverage Ratio2.06
Current Ratio1.15
Price / Book1.43
Price / Cash Flow13.42
Price / Free Cash Flow18.53
Debt / Equity0.62
Price / Sales2.27
PEG Ratio0.47

Financial Strength

Altman Z-Score1.29
Piotroski F-Score 7 / 9
Beneish M-Score-2.48
Price to Intrinsic Value0.81
1-Year Target Price23.08
Shiller PE Ratio46.20
Short Ratio1.21
Short % of Float0.10

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 3.31% 86 / 100   
1 Month 17.08% 96 / 100   
2 Months 19.9% 94 / 100   
6 Months 25.81% 93 / 100   
1 Year 51.85% 93 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog